Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
NIDAN
NIDAN

Nidan Laboratories And Healthcare Ltd.

NSE: NIDAN
SME
Sector: Healthcare
Industry Group: Healthcare Services
12.30-0.4 (-2.77%)
23 Oct, 12:00 AM

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap
17.10
P/E (TTM)
11.35
P/B
0.25
P/S (TTM)
0.67
EV/EBITDA
1.30
CAPE (5Y)
12.20
ROE (TTM)
2.18
ROCE (TTM)
22.91
ROA (TTM)
1.80
Avg 3Y ROE
0.12
Earnings 3Y CAGR
-24.87
Sales 3Y CAGR
1.72
Sales 5Y CAGR
3.17
Debt/Equity
0.16
Consensus TP
-
Strong Buy %
-
Promoter Holding
57.04
Pledged %
0.00

Share Price

Track Nidan Laboratories And Healthcare Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

12.30-0.4 (-2.77%)
-33.15% in past 1 year
1 Week returns: -5.38 %
Low
12.1
High
13.4
1 Month returns: -10.22 %
Low
12.1
High
13.9
1 Year returns: -33.51 %
Low
11.5
High
24.9
3 Year CAGR: -26.74 %
Low
11.5
High
41.2
5 Year CAGR: –
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Stock Analysis

Fundamental analysis overview of Nidan Laboratories And Healthcare Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views
Red Flags
Positive
Stock is cheap and PE TTM is at a discount to industry median

PE TTM of 11.35 indicates that the stock is cheap on a standalone basis. Discount to industry median P/E is decent at -43.67%

What is P/E Ratio?

Median: 20.15
Value 11.35
3.57344.87
Negative
Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral
Not enough talking points with neutral stance
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.00788595.

Financial Snapshot

See detailed analysis

Multi-year trends for Nidan Laboratories And Healthcare Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY
00k0k0k24.3 CrMar 202324.2 CrMar 202424.5 CrMar 202525.5 CrMar 2026
Profit After Tax FY
-0k-0k-0k-0k00k0k0k0k3.5 CrMar 2023-3.2 CrMar 20242.0 CrMar 20251.5 CrMar 2026
ROE FY
-6%-4%-2%0%2%4%6%5.2%Mar 2023-4.8%Mar 20242.9%Mar 20252.2%Mar 2026
EBITDA FY
00k0k0k21.2 CrMar 202321.3 CrMar 202421.5 CrMar 202520.2 CrMar 2026

Nidan Laboratories And Healthcare Ltd. Shareholding Pattern

Quarterly breakdown of Nidan Laboratories And Healthcare Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Total Promoter
71.22
71.22
71.22
62.79
57.04
57.04
57.04
57.04
57.04
57.04
57.04
57.04
Indian Promoter
71.22
71.22
71.22
62.79
57.04
57.04
57.04
57.04
57.04
57.04
57.04
57.04
Foreign Promoter
0.00
0.00
-
-
-
-
-
-
-
-
-
-
Institutions
0.00
0.00
-
-
0.00
-
0.00
0.00
0.00
0.00
0.00
0.00
Mutual Funds / UTI
0.00
0.00
-
-
-
-
-
-
-
-
-
-
FI/Bank/Insurance
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Govt
0.00
0.00
-
-
-
-
-
-
-
-
-
-
FII
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Institutions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Non-Institution
28.79
28.78
28.78
37.21
42.96
42.96
42.96
42.96
42.96
42.96
42.96
42.96
Bodies Corporate
1.08
1.40
0.13
0.24
0.53
0.27
0.21
0.13
0.13
0.12
0.14
0.14
Others (incl. Retail)
No. of shareholders
27.71
2,777
27.38
2,500
28.65
2,423
36.97
2,756
42.43
2,821
42.69
2,770
42.75
2,564
42.83
2,473
42.83
2,421
42.84
2,347
42.82
2,344
42.82
2,308

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Nidan Laboratories And Healthcare Ltd. shares as reported to NSE and BSE.

NameDateTypePriceQty.Value
VAGHANI VIRAJ04 May 2026sell₹ 13.1780.00 k₹ 10.54 lac
VAGHANI VIRAJ28 Nov 2025buy₹ 21.9880.00 k₹ 17.58 lac
SATYA PRAKASH MITTAL07 Mar 2025sell₹ 21.6589.00 k₹ 19.27 lac
NEELAM MITTAL07 Mar 2025buy₹ 21.6589.00 k₹ 19.27 lac
MITTAL PUNEET01 Jul 2024sell₹ 37.8487.00 k₹ 32.92 lac
MITTAL PUNEET01 Jul 2024buy₹ 37.9587.00 k₹ 33.02 lac
MITTAL PUNEET28 Jun 2024sell₹ 37.641.92 lac₹ 72.27 lac
MITTAL PUNEET28 Jun 2024buy₹ 37.291.92 lac₹ 71.60 lac
MITTAL PUNEET24 Jun 2024sell₹ 34.3473.00 k₹ 25.07 lac
MITTAL PUNEET24 Jun 2024buy₹ 33.6787.00 k₹ 29.29 lac
…

No corporate action data available.

Company Profile

Overview of Nidan Laboratories And Healthcare Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Nidan Laboratories and Healthcare Limited is an India-based company. The Company is engaged in providing diagnostic services including pathology, radiology, cardiology, and neurology. Its laboratory tests offer a range of over 6000 clinical laboratory tests and profiles, which are used to provide di...
Key personnel
Dr. Nitin Vitharao Thorve
Chief Executive Officer
Ms. Varsha Maniar
Compliance Officer, Company Secretary
Ms. Tejal Anil JayakarD
Chief Financial Officer, Executive Director
Mr. Edwin Francis DabreD
Executive Director
Mr. Krupesh Deepak ThakurD
Non-Executive Director
Mr. Nilesh Ghanshyam BideD
Non-Executive Independent Director
Dr. Abhijeet Ramesh DhanegaonkarD
Non-Executive Independent Director
Mr. Abhinay Shashikant NerurkarD
Non-Executive Independent Director
Incorporated on
05 Dec 2000
Last Annual
31 Mar 2026
Last Interim
31 Mar 2026
No. of Employees
149
IPO date
12 Nov 2021
Free Float
-
Address
-

Frequently Asked Questions

What is the current share price of Nidan Laboratories And Healthcare Ltd.?
The current share price of Nidan Laboratories And Healthcare Ltd. is ₹ 12.30 as of 23 Oct 2026.
What is the market capitalisation of Nidan Laboratories And Healthcare Ltd.?
The market capitalisation of Nidan Laboratories And Healthcare Ltd. stands at ₹ 17.10 Cr.
What is the PE ratio of Nidan Laboratories And Healthcare Ltd.?
The Price-to-Earnings (PE) ratio of Nidan Laboratories And Healthcare Ltd. is 11.35 as of the latest trailing twelve months data.
What is the ROE and ROCE of Nidan Laboratories And Healthcare Ltd.?
Nidan Laboratories And Healthcare Ltd. has a Return on Equity (ROE) of 2.18% and a Return on Capital Employed (ROCE) of 22.91% as per the latest financial reports.
What is the 52-week high and low of Nidan Laboratories And Healthcare Ltd.?
The 52-week high of Nidan Laboratories And Healthcare Ltd. is - and the 52-week low is -.
What is the dividend yield of Nidan Laboratories And Healthcare Ltd.?
The dividend yield of Nidan Laboratories And Healthcare Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Nidan Laboratories And Healthcare Ltd.?
Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 42.82% of Nidan Laboratories And Healthcare Ltd. shares.
What sector does Nidan Laboratories And Healthcare Ltd. belong to?
Nidan Laboratories And Healthcare Ltd. operates in the Healthcare sector.
What is the beta of Nidan Laboratories And Healthcare Ltd.?
The beta of Nidan Laboratories And Healthcare Ltd. is 0.90, indicating its price volatility relative to the broader market.
What is the RSI of Nidan Laboratories And Healthcare Ltd.?
The 14-day Relative Strength Index (RSI) of Nidan Laboratories And Healthcare Ltd. is 40.86, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.